Skip to main content

Free Resources

Industry Articles

Articles

Cell & Gene Market Outlook

I bet you can’t say “cell & gene therapies” three times fast. And by the time you do, you’ll have missed another article on your newsfeed discussing their intricacies and the headaches they can cause. Here’s one from Industry Standard…
Stephen Baker
April 7, 2022
Articles

CTMS Benchmarking & Market Dynamics

ISR’s CTMS Benchmarking & Market Dynamics (3rd Ed.) aims to tackle clinical trial management systems (CTMS) by helping providers and sponsors alike better understand current trends surrounding this technology and anticipate future ones. This report is the result of primary…
Stephen Baker
March 18, 2022
Articles

Hybrid Trials Are Here To Stay

Hybrid trials. Decentralized trials. Remote trials. Virtual trials. No matter what you (or anyone else) call them, the rapid uptake of trials in which patients participate from home for some visits/activities rather than exclusively in a clinical setting has been…
Stephen Baker
March 9, 2022
Articles

Warming Up To Hybrid Trials

Vice President of Market Research at Industry Standard Research Rebecca McAvoy analyzes results from a recent study indicating that COVID-19 has made sponsors more willing to run hybrid trials. “In a November 2020 survey, Industry Standard Research (ISR) asked 121…
Stephen Baker
March 3, 2021
Articles

Rare Disease Studies: A Comfortable Patient Is A Retained Patient

Market Research Director at Industry Standard Research Sherry Hubbard-Bednasz discusses rare disease patient retention. Industry Standard Research recently developed research aimed at understanding the nuances associated with rare disease studies. “Specifically, what does the uphill battle of patient retention look…
Tyler
October 31, 2020
Articles

Small And Emerging Biopharma Companies Outsourcing Practices

Market Research Manager at Industry Standard Research Patrick Olsen discusses ISR's recent small & emerging biopharma research activities, identifying their specific needs and how they differ from those of larger sponsors. “When looking at the attributes individually, small and emerging…
Tyler
September 23, 2020
Articles

Provider Selection In Small And Emerging Pharma Companies

Vice President of Market Research at Industry Standard Research Rebecca McAvoy discusses how the decision-making dynamics at small and emerging biopharma differ from their larger counterparts, and how service providers can leverage those to their advantage. “The lack of PPAs…
Tyler
July 10, 2020